Endovenous laser treatment (EVLT) has become one of the most popular and successful treatments for varicose veins. Prof Mark Whiteley is an internationally recognised expert in treating varicose veins with the new endovenous treatments.
Prof Mark Whiteley teaching EVLT endovenous laser for varicose veins theory on Angiodynamics course 9 Feb 2017 The Whiteley Clinic
The National Institute for Health and Clinical Excellence (NICE) as recommended endovenous thermal ablation as the first-line treatment for varicose veins. EVLT is one of the endovenous thermal ablation techniques and so is nice recommended (see: nice.org.uk/guidance/cg168/).
Prof Mark Whiteley started teaching endovenous surgery in 1999, following being the first doctor in the UK to use this new treatment in March 1999. In those days he used radiofrequency.
Since 2005, the numbers of cases suitable for endovenous laser has surpassed those suitable for radiofrequency. Although many other techniques are available, endovenous laser (EVLT) is the most commonly used technique and The Whiteley Protocol.
Prof Mark Whiteley started running AngioDynamics EVLT courses in August 2012 and has been running them regularly ever since.
The courses allow doctors, nurses and vascular scientists to come to The Whiteley Clinic and see the optimal way of treating varicose veins.
The two-day course also allows Prof Whiteley and his team to present their latest research, showing how to get the very best out of all vein treatments. Not only do they show research about EVLT, but they also teach about pelvic vein reflux, perforator vein incompetence, venous leg ulcers and different treatments including perforator vein treatments and foam sclerotherapy.
The EVLT course, supported by Angiodynamics, has become a very popular teaching course in the venous world. The first day focuses on theory and the second day, features live operating. Live operations at The Whiteley Clinic in Guildford are observed via video link in real time.
Delegates are able to discuss cases directly with Prof Whiteley and his team during the procedure.